These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6344315)

  • 1. The clotting time of whole blood in plastic tubes: the influence of exercise, prostacyclin and acetylsalicylic acid.
    Osterud B; Brox JH
    Thromb Res; 1983 Feb; 29(4):425-35. PubMed ID: 6344315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.
    Czervionke RL; Smith JB; Fry GL; Hoak JC; Haycraft DL
    J Clin Invest; 1979 May; 63(5):1089-92. PubMed ID: 376548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU; Just M; Schlotte V; Seiffge D
    Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
    Ritter JM
    Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet activation by prostacyclin: possible consequences in coagulation and anticoagulation.
    Bunting S; Simmons PM; Moncada S
    Thromb Res; 1981 Jan 1-15; 21(1-2):89-102. PubMed ID: 7015559
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of acetysalicylic acid on changes in platelet function due to physical exertion.
    Rohrer TF; Pfister B; Imhof PR
    Arzneimittelforschung; 1977 Jul; 27(7):1490-3. PubMed ID: 578480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin can replace heparin in haemodialysis in dogs.
    Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
    Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prostacyclin on the coagulation of whole blood.
    Holloway DS; Zuckerman L; Vagher JP; Mockros LF
    Thromb Haemost; 1983 Oct; 50(3):671-5. PubMed ID: 6359571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of prostaglandins for the in vitro adhesiveness and in vivo margination of neutrophilic granulocytes].
    Fehr J; Bütler S
    Klin Wochenschr; 1985 Feb; 63(4):152-7. PubMed ID: 3884891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiaggregatory efficacy and its time-course after application of acetylsalicylic acid, prostacyclin and nafazatrom in vivo.
    Herrmann KS
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):150-8. PubMed ID: 6393886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.